service members even with the use of hearing protection devices (HPDs). Although
epidemiology and animal studies have been performed to investigate the damage formation
mechanism of blast-induced hearing damage, there is still a lack of understanding and
therapeutic solutions, especially for HPD-protected ears. Recent studies revealed the
potential therapeutic function of liraglutide, a glucagon-like peptide-1 receptor agonist, to …